# q01 rev 1 - independent review (fresh question-review), 2026-10-06

Raw return as received:

q01 is locally ready, with Medium suitability only marginal. Easy is the single most likely platform outcome, and no platform result exists, so status stays `checked`.

**q01 (rev 1; tested_sha256: 0c4ada79857fe6002f3e54c31fc4c9ba16909a3d678a0fee82bef0a049662c74)**

**gold_verified: yes.** I rebuilt "Flat" from the originals.
- **Event:** Doc 6 (D05) says U.S. Consulting Services "was divested in April 2026" (l.81, l.269, l.393). The same l.81 sentence places it among businesses "grouped together in Other". l.95 says Q3 sales fell "due to the April 2026 divestiture", so the sale was complete. "Completed the divestiture" is the ordinary meaning of "was divested", so the premise holds.
- **Other's FY2026 adjusted operating income guidance, by issue date:**
  - Doc 3 (D06), Nov 5, 2025: "1% to 4% decline"
  - Doc 4 (D01), Feb 4, 2026: "Flat"
  - Doc 5 (D03), May 6, 2026: "High-single digit growth"
  - Doc 6 (D05), Aug 5, 2026: "~10% growth"
- **Date check (script):** all 30 April 2026 days fall under the Feb 4 edition. Doc 5's "previous range of $17.45 to $17.75" is Doc 4's reaffirmed range, so the next earnings release changed nothing before May 6.
- **Other candidates, all excluded by the wording:**
  - Doc 4's Other revenue row ("1% to 5% growth"), excluded by the line item.
  - The company-wide 11.5%–13.5%, excluded by the group.
  - U.S. Healthcare Solutions rows, excluded because from FY2026 that segment excludes legacy U.S. Consulting.
- **Residual:** no update between Feb 4 and April rests on the EPS link. Doc 6's "$17.70 to $17.90" against Doc 5's $17.65 shows an off-release update only after May 6.

**outcome: A: match; B: match.** Both packets are fresh, and their text hashes equal the snapshot. Both answered "Flat" from Doc 6 plus Doc 4 with high confidence. Each named and rejected the Doc 5, Doc 6 and Doc 3 values; B also rejected the company-wide figure.

**closed-book: misses.** It answered "About 9% to 11%" for U.S. Healthcare Solutions, at low confidence. That is not equivalent to Flat. It is the third local miss (rev 0: 8%–10%; sketch screen: 3%–7%).

**necessity:**
- **Doc 6 (D05)** is the only source of the completion date: "April" occurs nowhere else. Docs 4 and 5 say only "held for sale", and Doc 5 still lists the business in Other.
  - I checked the rev 1 removal probe packet: ids renumbered, neutral folder name, verbatim question.
  - Without Doc 6 the probe answered "High-single digit growth" (p 0.5), with Flat only at p 0.25. That is off the gold.
- **Doc 4 (D01)** is the only FY2026 source of "Flat". The only other "flat" hits are FY2025 International lines (D02 l.115, D04 l.117). No later release restates it.
  - Without Doc 4, the latest edition before April is Doc 3's decline.
  - The rev 0 probe answered decline (p 0.70). Its logic carries over to the new wording, because the April date is present either way.
- **Doc 5 (D03)** is not necessary: without it, Doc 4 is still the latest edition before April. The two FY2025 releases (Docs 1 and 2) are irrelevant.
- Doc 4 plus Doc 6 is the minimal set; no smaller set exists.

**shortcut: clear.** The verified route is Doc 6 l.81 (April 2026, Other), then the release dates (Doc 4 l.17, Doc 5 l.15), then Doc 4 l.114. That is three lookups and one date comparison. No passage holds both the event and "Flat". The capture overview lists "April 2026" among Doc 6's dates without context, and gives no Other outlook.

**source_assessment: no known gaps.**
- intake.json shows all six documents matching the capture, with zero gap characters, and the report lists no source gaps.
- The originals total 308,612 characters against the capture's 308,606, about one trailing newline per document. Source hashes equal the snapshot.
- The bold type marking updated guidance figures is lost in the text, but it affects no premise and not the gold.

**difficulty: medium (marginal).** This is local suitability only.
- **Pushes it harder:**
  - It reuses the aq-00964 q01 mechanism, which measured Medium.
  - The event appears only in the latest release, beside that release's own later "~10% growth".
  - A second decoy sits in between: Doc 5, whose quarter ended March 31, invites a period-end versus issue-date error.
  - Doc 6's guidance update is not tied to the sale.
- **Pulls it easier:**
  - The month is printed plainly, and "then-current" signals the timing check.
  - The answer is a printed label, with no calculation after choosing the edition.
  - Doc 4 l.47 and l.103 tie Other's February change to this business's write-down, so a model can reach Flat for the wrong reason.

Platform estimate:

| Outcome | Rough probability |
| --- | --- |
| Too easy | ~10% |
| Easy | ~35% |
| Medium | ~30% |
| High | ~12% |
| Too hard | ~5% |
| Low 0/5 then Medium 4–5/5 (outcome not yet seen) | ~8% |

Medium or better is about 45–50%. The rewording leaves these odds essentially unchanged, at most about 5 points toward Easy. Its effect is on the document check: the risk of the "may not be needed" flag on Doc 6 drops from about 50% (rev 0 probe: Flat at p 0.5) to roughly 15–25%.

**verdict: ready.** This covers local checks only; status stays `checked` until a platform pass at Medium.

**findings:**
1. **Verbatim evidence on the platform (unknown, blocking, pre-submission).** The quote "Other(2)|Flat|$352M" spans table cells, and a single cell is under 12 characters. Use Save passage on Doc 4's row. If the platform text differs, the evidence changes, which means a new revision, a new fingerprint and fresh A/B, audit and closed-book runs.
2. **Doc 6 removal check (residual, about 15–25%).** The platform's high model makes two attempts without each document, and how it scores a split is unknown. Optionally run a second no-Doc-6 probe, and a no-Doc-4 probe on the rev 1 wording to replace the rev 0 record.
3. **Original question (blocking platform check, unknown).** The question is almost word for word aq-00964 q01's frame: "When American Tower completed the sale of its Philippines subsidiary, what ... was its then-current outlook projecting for the segment that included that subsidiary?" This surfaces in the full checks, before any difficulty run.
4. **Doc 5 in the reasoning.** Step 2 quotes Doc 5, which is unlisted and has no Evidence quote. That is consistent with the policy. If Derive the rest proposes marking it, decline.
5. **Reasoning-number rule (my emulation, unconfirmed on the form).** Every number is in its step's document. The Decoy line names Doc 6 and Doc 5; its date and "~10%" are only in Doc 6.
6. **Q9, Q10, rule 10.** 31 words, one ask, fiscal 2026 and the line item pinned. The answer is a fact about the world, and "0%" or "no growth" are equivalent forms.
7. **Stale note (outside the fingerprint).** The "Style/set review" lever-check line still says "anchor scope fixed by 'when Cencora divested'".
8. **Set.** q02 shares the "completed X" anchor style, but with a different event, document pair and calculation. There are no mutual giveaways.
9. **Authorship.** Origin is claude, and the export accepts only user. That is reported separately; the choice is yours.
